Paper5773321
Biologic and immunologic characteristics of cold-adapted influenza virus.
Maassab HF. J Immunol, 1969. Cited by 128 papers, by iCite.
Cite this record
ConductScience Library. Biologic and immunologic characteristics of cold-adapted influenza virus. Papers, record 5773321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5773321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Orthomyxoviridae | Major topic |
| Animals | |
| Cold Temperature | |
| Hemagglutination Inhibition Tests | |
| Hemagglutination Tests | |
| Hydrogen-Ion Concentration | |
| Mice | |
| Rodentia | |
| Virulence |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01097941 | Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children | Background | ClinicalTrials.gov | |
| NCT01246999 | Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children | Background | ClinicalTrials.gov |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41173917 | Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection. | Nat Commun | 2025 | https://conductscience.org/library/papers/41173917 | PubMed |
| 41071743 | Vaccine and Treatment Evaluation Units: A Historical Perspective. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/41071743 | PubMed |
| 41071740 | From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/41071740 | PubMed |
| 40539815 | Implications of morphological variation in influenza viruses. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/40539815 | PubMed |
| 39591123 | Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39591123 | PubMed |
| 35746534 | Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35746534 | PubMed |
| 35409297 | Antiviral Effects of ABMA and DABMA against Influenza Virus In Vitro and In Vivo via Regulating the Endolysosomal Pathway and Autophagy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409297 | PubMed |
| 34073843 | Selecting and Using the Appropriate Influenza Vaccine for Each Individual. | Viruses | 2021 | https://conductscience.org/library/papers/34073843 | PubMed |
| 32253347 | Live Attenuated Cold-Adapted Influenza Vaccines. | Cold Spring Harb Perspect Med | 2021 | https://conductscience.org/library/papers/32253347 | PubMed |
| 29093096 | MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts. | J Virol | 2018 | https://conductscience.org/library/papers/29093096 | PubMed |
| 27930325 | Development of high-yield influenza B virus vaccine viruses. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27930325 | PubMed |
| 27486731 | Human Influenza Virus Infections. | Semin Respir Crit Care Med | 2016 | https://conductscience.org/library/papers/27486731 | PubMed |
| 27155495 | Development of a stable liquid formulation of live attenuated influenza vaccine. | Vaccine | 2016 | https://conductscience.org/library/papers/27155495 | PubMed |
| 26269186 | Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias. | J Virol | 2015 | https://conductscience.org/library/papers/26269186 | PubMed |
| 25552727 | Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine. | J Virol | 2015 | https://conductscience.org/library/papers/25552727 | PubMed |
| 23596576 | Principles underlying rational design of live attenuated influenza vaccines. | Clin Exp Vaccine Res | 2012 | https://conductscience.org/library/papers/23596576 | PubMed |
| 23223214 | Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza. | Viruses | 2012 | https://conductscience.org/library/papers/23223214 | PubMed |
| 21760928 | Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. | PLoS One | 2011 | https://conductscience.org/library/papers/21760928 | PubMed |
| 21060780 | Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. | PLoS One | 2010 | https://conductscience.org/library/papers/21060780 | PubMed |
| 20118381 | Influenza vaccines: from surveillance through production to protection. | Mayo Clin Proc | 2010 | https://conductscience.org/library/papers/20118381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5773321
GET https://conductscience.org/api/papers/v1/5773321/cited_by?page=2